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Mechanisms of Gal1-3Gal1-4GlcNAc-R (Gal)
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Objective: We have previously reported that porcine valve endothelium does not
express immunodetectable levels of the carbohydrate Gal1-3Gal1-4GlcNAc-R
(known as Gal), suggesting that fresh porcine valve may be immunoprivileged. In
this study, we further investigated the mechanisms of Gal expression on porcine
valve endothelial cells.
Methods: Primary cultures of porcine valvular endothelial cells were established and
compared with porcine aortic endothelial cells and human vein endothelial cells.
Immunoblotting, reverse transcriptase-polymerase chain reaction, and flow cytom-
etry were used to compare the expression of Gal at both the protein and messenger
RNA levels.
Results: Porcine valvular endothelial cells grew rapidly on a gelatin substrate.
Similar to our previous in vivo results, valve endothelial cells expressed Gal much
less intensely than did aortic endothelial cells. Porcine aortic endothelial cells
expressed an isolectin B4 (isolectin B4 lectin Bandeiraea simplicifolia) immuno-
detectable band at 135 kd that was not visible on porcine valve endothelial cells or
on human vein endothelial cells. Reverse transcriptase-polymerase chain reaction
documented three transcripts of the Gal gene that were identically expressed on
porcine valve and aortic endothelial cells. Furthermore, flow cytometry showed an
almost identical surface profile between porcine aortic and valve endothelial cells,
in contrast with human vein endothelial cells.
Conclusions: Cultures of primary valve endothelial cells were established and
exhibited similar phenotypic patterns in vitro to those we have previously docu-
mented in vivo. RNA and flow cytometric analyses documented no difference
between the RNA expression and surface protein profile for Gal, although whole-
cell extracts demonstrated an immunodetectable band on Western blotting that was
present on aortic endothelial cells but not on valve endothelial cells. These findings
clarify the mechanism of expression of 1,3galactosyltransferase gene expression in
valve endothelial cells, suggesting that delayed rejection of fresh porcine cardiac
valves may occur.
Valve research during the past 4 decades has attempted to producethe ideal replacement valve. Current research has been broadlydivided along the lines of mechanical versus bioprosthetic valves.Although the ideal prosthetic valve does not yet exist, its charac-teristics have been well defined.1 It should provide excellenthemodynamic properties, provide durability, and have a minimal
need for anticoagulation.
The development of a long-term viable bioprosthesis has been hampered by
structural deterioration when placed into younger patients needing valve replace-
ment.2 It has been theorized that a viable bioprosthesis would contain regenerating
fibroblasts and valve endothelial cells to provide a turnover of matrix and anti-
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thrombotic factors. Fibroblasts could produce collagen to
stiffen the underlying valve matrix. Valvular endothelial
cells could provide the proper balance between procoagu-
lant and anticoagulant forces to minimize the need for
long-term anticoagulation. The hemodynamic benefits of
bioprostheses might be realized without the long-term struc-
tural deterioration that some have linked to glutaraldehyde
fixation. Concern has been expressed that a viable endothe-
lial surface displays immunologically xenoreactive
epitopes, such as major histocompatibility complex class II,
intracellular adhesion molecule 1, CD54, and E-selectin, on
the surface of valve endothelium.3,4 For example, some
centers have demonstrated that ABO mismatch is an inde-
pendent predictor of graft deterioration, and typing thus
may improve the long-term outcomes of homograft valves,5
although this is controversial.6
The interaction between primate xenoreactive antibodies
and the carbohydrate Gal1-3Gal1-4GlcNAc-R (Gal) is
the major acute obstacle faced when xenotransplanting por-
cine tissue.7 The Gal epitope is synthesized by the glyco-
sylation enzyme 1,3galactosyltransferase. The Gal
epitope is homologous to the ABO blood group antigens; in
effect, pigs have an additional blood group antigen.
We have demonstrated that native porcine cardiac valves
do not have any immunohistochemically detectable Gal on
the surface, as shown by immunostaining with isolectin B4
(IB4) lectin.8 Furthermore, when hearts from transgenic
swine expressing human complement regulatory proteins
(CD59 and decay-accelerating factor) are implanted into
baboons, the valves, unlike the myocardium, are spared
from immunoglobulin M and membrane attack complex
deposition, thought to be initiated by the expression and
binding of xenoreactive antigens to endothelially expressed
Gal.9 We later found that freshly harvested human cardiac
valves have no immunohistochemically detectable ABO
blood group antigens, which are the human homologs of
Gal, on their surface.10 We then attempted to use cell
culture to define the surface epitopes on human vein endo-
thelial cells and human saphenous vein endothelial cells. In
culture, they appeared to lack ABH reactivity,6,11 although
they have been shown to stimulate human T-cell prolifera-
tion and interleukin 2 release.3
Because saphenous vein endothelial cells may not be a
good proxy for valve endothelial cells, we established cul-
tures of porcine aortic endothelial cells and porcine valve
endothelial cells and applied Western blotting, immunohis-
tochemical methods, RNA analysis, and flow cytometry to
aortic and valve endothelial cells to investigate further the
mechanism of Gal expression.
Material and Methods
Supplies
Bandeiraea simplicifolia IB4 lectin; both fluorescein isothiocya-
nate-conjugated and biotinylated IB4 lectin; Ricinus communis
agglutinin I lectin (RCA lectin, or Gal); Thermophilus aquaticus
(Taq) DNA polymerase; gelatin (2% solution type B from bovine
skin); mineral oil; heparin sulfate; protease inhibitor cocktail (pep-
statin A, leupeptin, bestatin, aprotinin, and E-64; P 8340); bicin-
choninic acid protein assay kit, collagenase (from Clostridium
histolyticum); monoclonal anti-smooth muscle cell -actin (A-
2547); diaminobenzidine; penicillin G, streptomycin, and glu-
tamine solutions, trypsin-EDTA solution for endothelial cells; and
Tri-Reagent were purchased from Sigma (St Louis, Mo). Oligo-
nucleotide primers for human -actin were purchased from Strat-
agene (LaJolla, Calif). Oligonucleotides created for reverse tran-
scriptase-polymerase chain reaction (PCR) for Gal were
purchased from Sigma Genosys (Woodlands, Tex). Precast aga-
rose gels (4%), prestained molecular weight markers, and precut
0.20-m polyvinylidene difluoride membranes were purchased
from Invitrogen Corporation (Carlsbad, Calif). Casein (I-block)
was purchased from Tropix (Bedford, Mass). Endothelial cell
growth factor was purchased from (Roche Diagnostics Corpora-
tion, Laboratory Systems (Indianapolis, Ind). Human vein endo-
thelial cells (catalog CRL-1730) and Kaighn F-12 medium were
purchased from American Type Culture Collection (Manassas,
Va). Primary cultures of porcine aortic endothelial cells were
ordered from Cell Systems (Kirkland, Wash). The Vectastain Elite
avidin-biotin complex kit was purchased from Vector Laborato-
ries, Inc (Burlingame, Calif). Superscript II reverse transcriptase,
medium 199 with Earle salts, Dulbecco phosphate-buffered saline
solution lacking calcium or magnesium, and gentamicin were
purchased from Life Technologies, Inc (Rockville, Md). Fetal calf
serum (heat inactivated) was purchased from HyClone Laborato-
ries Inc (Logan, Utah). Adult 50-kg female pigs were purchased
from Parson Farms (Hadley, Mass). Sodium pentobarbital was
purchased from Delmarva Laboratories (Midlothian, Va). Six-well
tissue culture plates were purchased from Denville Scientific
(Metuchen, NJ). Crystal/Mount was purchased from Biomeda
Corp (Foster City, Calif).
Immunohistochemical Studies
Cells were grown to near confluence on plastic tissue culture-
treated slides. Cells were fixed for 10 minutes in ice-cold 10%
methanol and phosphate-buffered saline solution. For lectins, a
1:100 solution of biotinylated IB4 lectin or RCA lectin was applied
for 1 hour at room temperature. Slides were then developed by
incubating for 30 minutes in avidin-biotin complex, which was
then developed with diaminobenzidine. Washes for lectins were
done with phosphate-buffered saline washes without polysorbate
(Tween) 20. The high stringency of Tween 20 resulted in no
staining (data not shown). Counterstaining was with Gill hema-
toxylin for 1 minute. Slides were then mounted with an aqueous
mount. For smooth muscle cell -actin immunostaining, primary
antibody was used at a concentration of 1:10,000 in phosphate-
buffered saline solution and 1% bovine serum albumin for 1 hour.
Washes were all performed in phosphate-buffered saline solution
with Tween (0.5%). Secondary antibody incubation (1:2000 in
phosphate-buffered saline solution with Tween) was for 1 hour at
room temperature. Avidin-biotin complex reagent was then ap-
plied for 1 hour, and diaminobenzidine was used as a substrate for
the horseradish peroxidase reaction.
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Sections of tissue were used as a control for antibodies. Sec-
tions were cut 4-m thick on a Leica microtome (Leica Micro-
systems Inc, Deerfield, Ill) from formalin-fixed, paraffin-embed-
ded tissues. Standard deparaffinization and dehydration were
performed. Tissue was treated with protease K for 10 minutes.
Incubation in avidin-biotin complex reagent alone served as a
nonspecific negative control preparation.
Cell Culture: Porcine Valvular Endothelial Cells
Primary cultures of porcine valvular endothelial cells were pre-
pared with the following modifications of previously published
methods. Hearts were removed under aseptic conditions from
domestic adult swine (50 kg) that were killed by injection of 87
mg/kg sodium pentobarbital. All animals were treated humanely in
compliance with the Guide for the Care and Use of Laboratory
Animals prepared by the Institute of Laboratory Animal Resources,
National Research Council, and published by the National Acad-
emy Press, revised 1996. The valve leaflets were removed from the
aortic and mitral valves and placed into phosphate-buffered saline
solution supplemented with antibiotics (100 U/mL penicillin G and
20 g/mL gentamicin). A margin of leaflet was left attached to the
anulus. Valve leaflets were washed free of red blood cells by three
washes with phosphate-buffered saline and antibiotic solution. The
valve leaflets were then placed in a 0.6-mg/mL collagenase solu-
tion (from C hystoliticum) in phosphate-buffered saline solution
supplemented with 100 U/mL penicillin G and 20 g/mL genta-
micin at 37°C for 15 minutes. The valve leaflet was then gently
shaken for 1 minute in medium 199. Cells that became dislodged
were then placed by aliquots into a 96-well plate into which
complete medium was added. Medium was changed every 48
hours. Cells were checked for expansion every day. Cells with
fibroblastic or smooth muscle cell morphologic and growth char-
acteristics, as evinced by spindle morphologic characteristics or
lack of contact inhibition, were discarded. Cells of typical endo-
thelial morphologic type were then expanded and confirmed to be
of endothelial cell origin by immunohistochemical methods. These
cells were used for subsequent experiments. Complete medium
consisted of medium 199 with Earle salts supplemented with 20%
heat-inactivated fetal calf serum, penicillin at 100 U/mL, strepto-
mycin at 0.1 mg/mL, L-glutamine at 2 mmol/L, endothelial cell
growth factor at 100 g/mL, and heparin at 50 g/mL. Cells were
subcultured at near confluence with a standard trypsin (500 BAEE)
and EDTA (180 g/mL) detachment procedure.
Porcine aortic endothelial cells were obtained during first pas-
sage (6 cumulative population doublings) and routinely used for
experiments between passages 4 through 6. They were isolated
from the aortas of large white pigs, as described by Ryan and
Maxwell.12 They were grown in complete medium 199, which was
changed every 48 to 72 hours. Human vein endothelial cells were
grown in Kaighn’s F12 medium supplemented with 10% heat-
inactivated fetal calf serum, penicillin (100 U/mL), streptomycin
(0.1 mg/mL), and L-glutamine (2 mmol/L), endothelial cell growth
factor (100 g/mL), and heparin (50 g/mL). Cells were subcul-
tured near confluence with trypsin.
Reverse Transcriptase-Polymerase Chain Reaction
RNA was extracted with previously described modifications13 of
the method of Chomczynski and Sacchi.14 In brief, endothelial
cells were lysed with 4 mL Tri-Reagent per 10-cm petri dish of
confluent cells. Chloroform was added at one fifth final volume
and the solution was vigorously vortex mixed. Nucleoprotein
complexes were then allowed to dissolve by letting the homoge-
nate sit for 15 minutes on ice. The solution was centrifuged for 30
minutes at 4°C and 12000g. The aqueous layer was then removed
and mixed with an equal volume of isopropanol. The solution was
precipitated overnight at 20°C. Subsequently, the isopropanol
and RNA mixture was centrifuged at 12000g for 30 minutes at
4°C. The resulting RNA pellet was washed with a total of 6 mL of
70% ethanol and centrifuged again at 7500g at 4°C for 15 minutes.
The RNA pellet extracted from cell culture was dissolved in 40 L
of water. RNA was quantified by absorbence at 260 nm, with a 260
nm/280 nm ratio of 1.7 to 1.9. All experiments were performed in
triplicate with identical results, and a single representative autora-
diograph is shown.
Reverse transcription was performed according to the Super-
script II directions. In brief, 2 g of total RNA was mixed with
oligodeoxythymidine primer (0.5 g/L) and annealed for 10
minutes at 70°C and then placed on ice. PCR buffer (20-mmol/L
tris[hydroxymethyl]aminomethane [Tris, pH 8.4] and 50-mmol/L
potassium chloride), magnesium chloride (2.5 mmol/L), deoxyri-
bonucleoside triphosphate (1 mmol/L), and dithiothreitol (10
mol/L) were added. Samples were heated to 42°C for 5 minutes,
at which point reverse transcriptase was added to the mixture. The
reaction was allowed to proceed for 50 minutes and then termi-
nated by 5 minutes of heating to 94°C. Five percent (1 L) of this
reaction was routinely used for PCR amplification.
The human -actin primer consisted of the sense sequence
5-TGA CGG GGT CAC CCA CAC TGT GCC CAT CTA-3 and
the antisense sequence 5-CTA GAA GCA TTT GCG GTG GAC
GAT GGA GGG-3, resulting in a 661-base pair (bp) fragment.15
Reverse transcription of the RNA extracts was performed from 2
g of total RNA with oligodeoxythymidine as initiation primer.
PCR amplification of a 5 fragment of the pig Gal coding region
was done with the following primers: 5-AGG AAG AGT GGT
TCT GTC-3, corresponding to nucleotides 12 through 30 of pig
1,3GT isoform 1, and 5-GTT ATG GTC ACG ACC TCT-3,
corresponding to nucleotides 324 through 306 of pig 1,3GT
isoform 1, as previously described elsewhere.16,17 PCR reaction
mix consisted of 100 pmol primers, 10 mmol/L-deoxyribonucleo-
side triphosphates, 3-mmol/L magnesium chloride, 10-mmol/L
Tris hydrochloride buffer, 50-mmol/L potassium chloride, 10%
glycerol, and 2 U Taq polymerase. Conditions for PCR reaction
were as follows: 94°C denaturing temperature for 30 seconds,
54°C hybridization for 30 seconds, and 72°C elongation temper-
ature. PCR was performed for 35 cycles. PCR reactions were
resolved on precast 4% agarose gels and stained with ethidium
bromide. Images were recorded with Polaroid 667 film (Polaroid
Corporation, Cambridge, Mass).
Western Blot
Porcine aortic endothelial cells, porcine valve endothelial cells,
and human vein endothelial cell monolayers were washed with
phosphate-buffered saline solution containing 5-mmol/L EDTA,
scraped from the flasks in phosphate-buffered saline solution and
EDTA, and centrifuged at 900g for 5 minutes at 4°C in a swinging
bucket centrifuge. Cell pellets were then lysed in 1 volume of lysis
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buffer (50-mmol/L Tris [pH 7.2] containing 2% Triton X-100 [The
Dow Chemical Company, Midland, Mich], 5-mmol/L EDTA, and
protease inhibitors [pepstatin A, leupeptin, bestatin, aprotinin, and
E-64]) for 1 hour on ice. After sedimentation of nuclei and debris
at 10,000g for 30 minutes, supernatants were collected and stored
at 80°C until use. Protein concentration was determined by the
bicinchoninic acid method, and 20 g of total protein per lane was
analyzed by immunoblotting. Aliquots of endothelial cell extracts
were subjected to sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis on an 8% gel under reducing conditions according to
the method of Laemmli.18 A second gel was run as a control to
ascertain equal loading and transfer, which was confirmed by
staining with Coomassie blue. Proteins were then transferred to a
0.45-mol/L polyvinylidene difluoride membrane at 125 V for 2
hours and stained with biotinylated IB4 lectin, according to minor
modifications of a previously described method.19 In brief, biotin-
ylated IB4 lectin was used at a 1:100 concentration (diluted in
phosphate-buffered saline solution) for 1 hour at room temperature
after blocking overnight with 0.2% casein and Tris-buffered saline
Tween (0.05%) solution at 4° C. The membrane was then washed
three times for 5 minutes each in phosphate-buffered saline solu-
tion. The Vectastain Elite kit was then used according to directions
to develop the immunoblot. It was critical to eliminate Tween from
the wash and incubation buffers, because the IB4 lectin displays no
signal in the presence of stringent wash conditions (data not
shown). Control blots were run in the absence of lectin and stained
with 3,3-diaminobenzidine with virtually no background signal.
As an additional control, blots included a lane of human vein
endothelial cell total protein extract, which is known not to express
Gal. All experiments were performed in triplicate, with a single
representative blot being shown.
Flow Cytometry
Cells were allowed to grow to near confluence and then harvested
with trypsin, which was neutralized in phosphate-buffered saline
solution with 1% bovine serum albumin, washed twice with phos-
phate buffered-saline solution, and resuspended in phosphate-buff-
ered saline solution with 1% bovine serum albumin. Flow cyto-
metric analysis was performed according to minor modifications of
previously published protocols20 by incubating 100 L (2  105
cells) of porcine aortic or valve endothelial cells or human vein
endothelial cells with 100 L of fluorescein isothiocyanate-conju-
gated IB4 lectin (20 g/mL) in phosphate-buffered saline solution
with 0.5-mmol/L calcium chloride for 30 minutes on ice. After
double washing with phosphate-buffered saline with 0.5-mmol/L
calcium chloride, the cells were resuspended in phosphate-buff-
ered saline solution and analyzed on an EPICS-XL flow cytometer
(Coulter Corporation, Hialeah, Fla) at 488 nm. Human vein endo-
thelial cells, which are known not to express Gal, served as a
negative control for the IB4 lectin. All experiments were per-
formed twice with one representative scan shown.
Results
Establishment of Porcine Valve Endothelial Cell
Culture
Because there are few standard descriptions and protocols
for the culture of primary porcine valve endothelial
cells,21,22 initial experiments were established to determine
the proper growth parameters. Cells grew rapidly when
placed on a 2% bovine gelatin substrate but not on standard
cell culture dishes (data not shown). Cells had typical cob-
blestone morphologic character and exhibited contact inhi-
bition in the presence of 20% fetal calf serum (data not
shown).
Immunohistochemical Studies
Cells were initially characterized by staining with the IB4
lectin to determine Gal reactivity. Whereas porcine aortic
endothelial cells (Figure 1, A) stained intensely with IB4
lectin, porcine valve endothelial cells (Figure 1, B) showed
minimal immunoreactivity for the IB4 lectin. Porcine myo-
cardium (Figure 1, C) served as both positive and negative
tissue controls for the lectin. Porcine myocardium stained
intensely in the capillaries and arterioles for Gal, whereas
cardiomyocytes were completely unstained and larger epi-
cardial vessels showed minimal reactivity. Cells were rou-
tinely photographed at 450 magnification and tissue sec-
tions were routinely photographed at 250 magnification.
To confirm that these were endothelial cells, we stained
them with the RCA lectin (Gal), which has been previ-
ously shown to be a mammalian endothelial cell marker.23
Both aortic (Figure 1, D) and valve (Figure 1, E) endothelial
cells stained positively for RCA, confirming their endothe-
lial origin. As a control, myocardium was stained, as shown
in Figure 1, F, with the RCA lectin. Endothelial cells, both
microvascular and large epicardial vessels, appeared to stain
intensely with this lectin, which is consistent with previ-
ously published reports.24
As further confirmation, immunohistochemical testing
was performed for smooth muscle cell -actin. Both aortic
(Figure 1, G) and valve (Figure 1, H) endothelial cells had
minimal reactivity toward smooth muscle cell -actin. As a
staining control, porcine myocardium was stained with the
same antibody (Figure 1, I). There was appropriate staining
in the smooth muscle layers of both arteries and veins.
In summary, valvular endothelial cells in culture exhib-
ited the same IB4 staining patterns (RCA positive, Gal
negative) in vitro as in vivo with respect to endothelial cell
phenotype.
Western Blot
Whole-cell homogenates were obtained for analysis of IB4
by immunoblotting. Twenty micrograms of total protein
from three different experiments was loaded for both por-
cine valve and aortic endothelial cells. Human vein endo-
thelial cells were included as a control, and a molecular
weight marker was used. There was an intensely positive
Gal band in aortic endothelial cells at 135 kd (Figure 2);
this band was lacking in porcine valve endothelial cells and
human vein endothelial cells. A less intense band was
evident at 125 kd in valve endothelial cells.
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Figure 1. Characterization by immunohistochemical staining of various cell types. A, Aortic endothelial cells
stained with IB4 lectin to detect Gal staining. B, Valve endothelial cells stained with IB4 lectin to detect Gal
staining. C, Porcine myocardium stained with IB4 lectin to detect Gal staining. D, Aortic endothelial cells
immunohistochemically stained with Gal, documented mammalian endothelial cell marker. E, Valve endothelial
cells immunohistochemically stained with Gal, documented mammalian endothelial cell marker. F, Porcine
myocardium immunohistochemically stained with Gal, documented mammalian endothelial cell marker. G, Aortic
endothelial cells immunohistochemically stained with antibody directed against smooth muscle cell -actin. H,
Valve endothelial cells immunohistochemically stained with antibody directed against smooth muscle cell
-actin. I, Porcine myocardium immunohistochemically stained with antibody directed against smooth muscle cell
-actin. All cells photographed at 450 magnification. Tissues photographed at 250 magnification.
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Reverse Transcriptase-Polymerase Chain Reaction
Total RNA was extracted from porcine aortic and valve
endothelial cells by the acid-guanidinium-thiocyanate
method. Two micrograms of total RNA was then reverse
transcribed into complementary DNA. Two hundred nano-
grams of complementary DNA, corresponding to a 10th of
the reaction, was then amplified with primers for human
-actin and porcine Gal. Three amplified products were
visualized for the Gal gene in both porcine aortic and
valve endothelial cells (Figure 3). These corresponded to
previously published sizes and distribution patterns.17 Al-
though reverse transcriptase-PCR is not an absolutely quan-
tifiable method but rather a relative one, it was obvious that
both samples contained similar amounts of amplified prod-
uct, in the same sizes, with similar amounts of -actin, a
constitutive gene that was coamplified. Sequencing revealed
that base pairs were 286, 313, and 349 nucleotides in length.
Films were scanned and intensity was measured. In contrast
to our findings with immunohistochemical and Western blot
analyses, there were no significant differences in band in-
tensity between transcripts from aortic and valve endothelial
cell messenger RNA.
Flow Cytometry With the IB4 Lectin
To determine whether there was any difference in the sur-
face profile of IB4 reactivity in intact cells, flow cytometry
was performed with fluorescein isothiocyanate-conjugated
IB4. Porcine aortic and valve endothelial cells and human
vein endothelial cells were harvested and mixed with fluo-
rescein isothiocyanate-conjugated IB4 and allowed to react
for 30 minutes on ice. Cells were then analyzed at 488 nm
by flow cytometry, and the curves are shown superimposed.
In agreement with our messenger RNA analysis, both aortic
and valve endothelial cells were almost identical in fluores-
cence intensity, in contrast to human vein endothelial cells
(which do not express Gal and served as a negative con-
trol; Figure 4).
Discussion
To clarify the immunogenicity of porcine valve endothe-
lium, we investigated the mechanisms underlying the ex-
pression of the Gal epitope on porcine valve endothelial
cells. Gal is the major xenoreactive epitope in the pig and
as such is the antigen responsible for hyperacute rejection of
porcine xenografts. We have previously shown that there is
no immunohistochemically detectable Gal on valve endo-
thelial cells, although there is intense Gal staining in
capillaries.8,25 As such, valve endothelium may represent
immunologically privileged tissue, suggesting a potential
role for a fresh cardiac valve prosthesis.
Results of this investigations shed new light on the
apparent lack of Gal epitopes on cardiac valve endothe-
Figure 2. Western blot of porcine aortic endothelial cells (PAEC) versus porcine valvular endothelial cells (PVEC)
in 6% polyacrylamide gel. In lanes 1 through 3 (from left) there is 20 g of porcine aortic endothelial cell protein
per lane. In lanes 4 through 6 there is 20 g of porcine valvular endothelial cell protein per lane. In lane 7 there
is human vein endothelial cell (HUVEC) protein as control. In lane 8 there is protein standard. Large arrow points
to 135-kd band, whereas small arrow corresponds to 115-kd band.
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lium. Whereas immunohistochemical and Western blot
analyses documented decreased Gal reactivity in valve
endothelial cells, flow cytometry and reverse transcriptase-
PCR demonstrated nearly equivalent surface epitope and
transcript profiles for Gal, implying that immunostaining
with the IB4 lectin may be ineffective in identifying rele-
vant Gal epitopes.
First, we established a method for the primary cultures of
valve endothelial cells. We documented that cultured valve
endothelial cells appeared to have similar phenotypic expres-
sion to that on valve leaflets. For example, cultured valve
endothelial cells exhibited typical cobblestone morphologic
type and were RCA lectin positive, confirming their endothe-
lial lineage.23 Furthermore, in contrast to porcine aortic endo-
thelial cells, valve endothelial cells expressed almost no Gal
according to IB4 immunostaining. This finding is similar to our
Figure 3. Reverse transcriptase-PCR of porcine aortic endothelial cells (PAEC) versus porcine valve endothelial
cells (PVEC). Cells were grown to confluence, RNA was extracted and reverse transcribed, and transcripts were
amplified with primers for Gal and -actin. In lane 1 there is 100-bp ladder with intense band at 600 bp. In lanes
2 and 3 there are porcine valve endothelial cell and porcine aortic endothelial cell extracts. -Actin (661 bp) and
Gal (3 transcripts at sizes 286, 313, and 349 bp) demonstrate equal intensity bands.
Figure 4. Flow cytometry of human vein endothelial cells (HUVEC), porcine valve endothelial cells (PVEC), and
porcine aortic endothelial cells (PAEC). To assess surface immunoreactivity of endothelial cells, fluorescein
isothiocyanate-conjugated labeled IB4 was incubated for 1 hour.
Surgery for Acquired Cardiovascular Disease Farivar, Filsoufi, Adams
312 The Journal of Thoracic and Cardiovascular Surgery ● February 2003
A
CD
previous reports,8,9 in which we documented that there was no
IB4 detectable staining on the endothelium of porcine cardiac
valves before or after xenotransplantation into primates. We
were also able to confirm by Western blot analyses that valve
endothelial cells expressed less IB4-detectable Gal than did
aortic endothelial cells. This is in good agreement with our
previous histologic results.
Reverse transcriptase-PCR demonstrated Gal gene ex-
pression on both aortic and valvular endothelial cells, also
demonstrating equivalent amounts of transcript in the two
cell types. The 1,3galactosyltransferase gene is alterna-
tively spliced from a single genomic locus that synthesizes
four proteins with variations in the length of the Golgi-
spanning stem region. These four isoproteins have all been
shown to have 1,3galactosyltransferase activity, with four
possible transcripts of 250, 286, 313, and 349 bp.26 Here we
demonstrated three transcripts, which is consistent with
previously published reports.17 This is the first report to our
knowledge of the differential display of these transcripts in
porcine valve endothelial cells. When compared with a
constitutive gene, such as the -actin gene, there are equal
amounts of all three transcripts.
Finally, flow cytometry with the IB4 lectin revealed
identical surface profiles in aortic and valve endothelial
cells, which were distinct from human vein endothelial
cells. This is consistent with the reverse transcriptase-PCR
activity of these cells. Apparently the IB4 lectin did not
have sufficient sensitivity in the harsh environment of his-
tochemical and Western washes to detect low levels of Gal
epitope expressed on the endothelial cell surface. In the
more gentle conditions of flow cytometry required for lec-
tin-Gal interactions, it is possible that there is a tighter
IB4-Gal interaction.
Most studies investigating the expression of Gal have
used the IB4 lectin from B (Griffonia) simplicifolia for
immunohistochemical23,27,28 or fluorescence-activated cell
sorter analyses.20 This lectin is from a family of tetravalent
lectins that bind Gal, with the IB4 lectin completely spe-
cific for Gal. Although its specificity is high, the sensitiv-
ity of the IB4 lectin may be insufficient for the detection of
small numbers of the Gal epitope. There is a low binding
affinity of each monomeric interaction of the IB4 lectin with
Gal. Because of this, it has been postulated that if the Gal
epitopes are not in close enough proximity to enable a
IB4-Gal interaction with more than one molecule of the
lectin (which has four combining sites), then the lectin may
be removed during overly stringent washes.29,30 This may
explain why, despite messenger RNA and fluorescence-
activated cell sorter analyses demonstrating transcript and
IB4-detectable Gal epitopes, respectively, there is minimal
staining by immunohistochemical means. Also, posttran-
scriptional modifications of glycoproteins or differences in
Gal presentation have been noted to affect the relative
abundance of immunodetectable Gal.31
Other tissue beds that have been thought to be immuno-
logically privileged have been shown to have low-level
expression of Gal epitopes. Indeed, it has been demon-
strated that despite a low expression of Gal epitopes in
bovine and porcine cartilage, there is a marked (20- to
100-fold) increase in anti-Gal activity when cartilage is
placed into suprapatellar pouches in cynomolgus mon-
keys.32,33 This emphasizes the need to remove all Gal
epitopes, because even a very low expression may be suf-
ficient to propagate a chronic rejection cascade.
This study confirms that porcine valve endothelium ex-
presses Gal epitopes in vitro, although these epitopes are
not detectable by immunohistochemical means. Further-
more, equivalent amounts of 1,3galactosyltransferase mes-
senger RNA isoforms are present in valve and aortic endo-
thelial cells, suggesting that any differences may be due to
posttranscriptional modifications or differences in antigen
presentation. Unless all Gal epitopes are removed from the
endothelium, such as by targeted gene disruption, our re-
sults suggest that fresh porcine valves are ultimately likely
to trigger delayed xenograft rejection.
We thank Mr Dean Santerre for his expert technical assistance
and Dr George Tellides for his helpful discussions.
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